文献速递安宁疗护多重用药老年慢病共病管理

老年退伍军人疗养院临终阶段阿司匹林停用发生率及预测因素

Incidence and Predictors of Aspirin Discontinuation in Older Adult Veteran Nursing Home Residents at End of Life.
PubMed 文献 · J Am Geriatr Soc · 2020-02-13

结果显示入住后90天内阿司匹林停用累积发生率为27%(95%CI 26%-28%),入院时明确记录预后有限者停用率为34%(95%CI 33%-36%),未记录者为24%(95%CI 23%-25%),且预测因素在两组间存在差异。

要点

  • 预期寿命有限/晚期痴呆退伍军人中约四分之一在入住疗养院90天内停用阿司匹林。
  • 入院时明确记录预后有限者阿司匹林停用率更高(34% vs 24%)。
  • 停用阿司匹林的预测因素在有无明确预后记录的两组人群中不同。

核心结论

  • 在预期寿命有限和/或晚期痴呆的老年退伍军人疗养院居民中,入住后90天内阿司匹林停用累积发生率为27%(95%CI 26%-28%)。
  • 入院时明确记录预后有限者的阿司匹林停用率(34%,95%CI 33%-36%)高于未记录者(24%,95%CI 23%-25%)。
  • 作者认为停用率仅略高于四分之一可能反映处方者对阿司匹林在临终阶段作用的认识不明确。

研究设计与样本

  • 回顾性队列研究,使用退伍军人事务部与Medicare临床/管理数据及Minimum Data Set居民评估数据链接。
  • 主要结局为入住后90天内阿司匹林停用(定义为连续14天未接受阿司匹林),采用以死亡为竞争风险的Fine和Gray子分布风险模型评估预测因素。

主要发现

  • 全样本阿司匹林停用累积发生率为27%(95%CI 26%-28%)。
  • 入院时明确记录预后有限者停用累积发生率为34%(95%CI 33%-36%),无此记录者为24%(95%CI 23%-25%)。
  • 各独立变量与阿司匹林停用的关联在入院时有无明确预后记录的两组居民中不同。

关键数值与推荐

  • 阿司匹林停用定义为入住后90天内连续14天未接受阿司匹林。
  • 纳入标准包括≥65岁、入住社区生活中心≥7天、预期寿命有限和/或晚期痴呆、有冠心病和/或卒中/短暂性脑缺血发作病史、入住第一周内使用阿司匹林。

临床怎么用

  • 对预期寿命有限和/或晚期痴呆的疗养院老年居民,应重新评估以阿司匹林进行二级预防的必要性。
  • 入院时明确记录预后有限可能影响阿司匹林停用决策,提示预后沟通与记录在临终用药管理中的作用。

局限性

  • 原文未报告研究局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Continuation of aspirin for secondary prevention in persons with limited life expectancy (LLE) is controversial. We sought to determine the incidence and predictors of aspirin discontinuation in veterans with LLE and/or advanced dementia (LLE/AD) who were taking aspirin for secondary prevention at nursing home admission, stratified by whether their limited prognosis (LP) was explicitly documented at admission. DESIGN: Retrospective cohort study using linked Veterans Affairs (VA) and Medicare clinical/administrative data and Minimum Data Set resident assessments. SETTING: All VA nursing homes (referred to as community living centers [CLCs]) in the United States. PARTICIPANTS: Older (≥65 y) CLC residents with LLE/AD, admitted for 7 days or longer in fiscal years 2009 to 2015, who had a history of coronary artery disease and/or stroke/transient ischemic attack, and used aspirin within the first week of CLC admission (n = 13 844). MEASUREMENTS: The primary dependent variable was aspirin discontinuation within the first 90 days after CLC admission, defined as 14 consecutive days of no aspirin receipt. Independent variables included an indicator for explicit documentation of LP, sociodemographics, environment of care characteristics, cardiovascular risk factors, bleeding risk factors, individual markers of poor prognosis (eg, cancer, weight loss), and facility characteristics. Fine and Gray subdistribution hazard models with death as a competing risk were used to assess predictors of discontinuation. RESULTS: Cumulative incidence of aspirin discontinuation was 27% (95% confidence interval [CI] = 26%-28%) in the full sample, 34% (95% CI = 33%-36%) in residents with explicit documentation of LP, and 24% (95% CI = 23%-25%) in residents with no such documentation. The associations of independent variables with aspirin discontinuation differed in residents with vs without explicit LP documentation at admission. CONCLUSION: Just over one-quarter of patients discontinued aspirin, possibly reflecting the unclear role of aspirin in end of life among prescribers. Future research should compare outcomes of aspirin deprescribing in this population. J Am Geriatr Soc 68:725-735, 2020.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Springer SP, Mor MK, Sileanu F, et al. Incidence and Predictors of Aspirin Discontinuation in Older Adult Veteran Nursing Home Residents at End of Life. J Am Geriatr Soc. 2020. PMID: 32052858. doi:10.1111/jgs.16346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。